Immunization with Cholera Toxin B Subunit Induces High-Level Protection in the Suckling Mouse Model of Cholera

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Price, Gregory A ^a   McFann, Kim ^b   Holmes, Randall K ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Food Science and Human Nutrition   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN B SUBUNIT; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; RECOMBINANT CHOLERA TOXIN B SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; CHOLERA; COHORT ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; IMMUNIZATION; IMMUNOPROPHYLAXIS; LD 50; MALE; MORTALITY; NEWBORN; NONHUMAN; NUMBER OF IMMUNIZATION; PREDICTIVE VALUE; PREVENTIVE HEALTH SERVICE; PROVOCATION TEST; SUCKLING; SURVIVAL RATE; VIBRIO CHOLERAE; WEIGHT REDUCTION;

ANIMALS; ANIMALS, SUCKLING; CHOLERA; CHOLERA TOXIN; CHOLERA VACCINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; MICE;

EID: 84874517872     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057269     Document Type: Article

References (54)

1. Sack DA, Sack RB, Nair GB, Siddique AK, (2004) Cholera. Lancet 363: 223-233.
2. Kaper JB, Morris JG Jr, Levine MM, (1995) Cholera. Clin Microbiol Rev 8: 48-86.
3. Zhang RG, Scott DL, Westbrook ML, Nance S, Spangler BD, et al. (1995) The three-dimensional crystal structure of cholera toxin. J Mol Biol 251: 563-573.
4. Chinnapen DJ, Chinnapen H, Saslowsky D, Lencer WI, (2007) Rafting with cholera toxin: endocytosis and trafficking from plasma membrane to ER. FEMS Microbiol Lett 266: 129-137.
5. Holmgren J, Lonnroth I, Svennerholm L, (1973) Fixation and inactivation of cholera toxin by GM1 ganglioside. Scand J Infect Dis 5: 77-78.
6. Spangler BD, (1992) Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev 56: 622-647.
7. Field M, Fromm D, al-Awqati Q, Greenough WB 3rd, (1972) Effect of cholera enterotoxin on ion transport across isolated ileal mucosa. J Clin Invest 51: 796-804.
8. Olsvik O, Wahlberg J, Petterson B, Uhlen M, Popovic T, et al. (1993) Use of automated sequencing of polymerase chain reaction-generated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae O1 strains. J Clin Microbiol 31: 22-25.
9. Ansaruzzaman M, Bhuiyan NA, Nair BG, Sack DA, Lucas M, et al. (2004) Cholera in Mozambique, variant of Vibrio cholerae. Emerg Infect Dis 10: 2057-2059.
10. Fazil MH, Kumar S, Farmer R, Pandey HP, Singh DV (2011) Binding efficiencies of carbohydrate ligands with different genotypes of cholera toxin B: molecular modeling, dynamics and docking simulation studies. J Mol Model.
11. Nair GB, Faruque SM, Bhuiyan NA, Kamruzzaman M, Siddique AK, et al. (2002) New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh. J Clin Microbiol 40: 3296-3299.
12. Nair GB, Qadri F, Holmgren J, Svennerholm AM, Safa A, et al. (2006) Cholera due to altered El Tor strains of Vibrio cholerae O1 in Bangladesh. J Clin Microbiol 44: 4211-4213.
13. Raychoudhuri A, Patra T, Ghosh K, Ramamurthy T, Nandy RK, et al. (2009) Classical ctxB in Vibrio cholerae O1, Kolkata, India. Emerg Infect Dis 15: 131-132.
14. Dubey RS, Lindblad M, Holmgren J, (1990) Purification of El Tor cholera enterotoxins and comparisons with classical toxin. J Gen Microbiol 136: 1839-1847.
15. Fujita K, Finkelstein RA, (1972) Antitoxic immunity in experimental cholera: comparison of immunity induced perorally and parenterally in mice. J Infect Dis 125: 647-655.
16. Guentzel MN, Berry LJ, (1974) Protection of suckling mice from experimental cholera by maternal immunization: comparison of the efficacy of whole-cell, ribosomal-derived, and enterotoxin immunogens. Infect Immun 10: 167-172.
17. Holmgren J, Svennerholm AM, Ouchterlony O, Anderson A, Walletstrom G, et al. (1975) Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization. Infect Immun 12: 1331-1340.
18. Kundu J, Mazumder R, Srivastava R, Srivastava BS, (2009) Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge. FEMS Immunol Med Microbiol 56: 179-184.
19. Neoh SH, Rowley D, (1972) Protection of infant mice against cholera by antibodies to three antigens of Vibrio cholerae. J Infect Dis 126: 41-47.
20. Peterson JW, (1979) Protection against experimental cholera by oral or parenteral immunization. Infect Immun 26: 594-598.
21. Pierce NF, Reynolds HY, (1974) Immunity to experimental cholera. I. Protective effect of humoral IgG antitoxin demonstrated by passive immunization. J Immunol 113: 1017-1023.
22. Stewart-Tull DE, Lucas C, Bleakley CR, (2004) Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase. Vaccine 22: 2137-2145.
23. Curlin GT, Levine R, Aziz KMA, Rahman ASM, and Verwey WF (1975) Field trial of cholera toxoid, p. 314-335. Proceedings of the Eleventh Joint Conference of the US-Japan Cooperative Medical Science Program: Department of Health, Education, and Welfare, Washington, D.C.
24. Levine MM, Nalin DR, Craig JP, Hoover D, Bergquist EJ, et al. (1979) Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity. Trans R Soc Trop Med Hyg 73: 3-9.
25. Noriki H (1976) Evaluation of toxoid field trial in the Philippines, p. 302-310. In H Fukumi and Y Zimaka (ed), Proceedings of the 12th Joint Conference of the US-Japan Cooperative Medical Science Program: National Institute of Japan, Tokyo, Japan.
26. Saletti M, Ricci A, (1974) Experiments with cholera toxin detoxified with glutaraldehyde. Bull World Health Organ 51: 633-639.
27. Peterson JW, Verwey WF, Craig JP, Guckian JC, Williams HR, et al. (1974) The response to glutaraldehyde toxoid in human volunteers-a progress report, p. 89-97. In H Fukumi and M Ohashi (ed), Proceedings of the 10th Joint Conference US-Japan Cooperative Medical Science Program: National Institute of Health, Tokyo Japan.
28. Glass RI, Svennerholm AM, Stoll BJ, Khan MR, Hossain KM, et al. (1983) Protection against cholera in breast-fed children by antibodies in breast milk. N Engl J Med 308: 1389-1392.
29. Qureshi K, Molbak K, Sandstrom A, Kofoed PE, Rodrigues A, et al. (2006) Breast milk reduces the risk of illness in children of mothers with cholera: observations from an epidemic of cholera in Guinea-Bissau. Pediatr Infect Dis J 25: 1163-1166.
30. Clemens JD, Sack DA, Harris JR, Chakraborty J, Khan MR, et al. (1986) Field trial of oral cholera vaccines in Bangladesh. Lancet 2: 124-127.
31. Holmgren J, Svennerholm AM, Lonnroth I, Fall-Persson M, Markman B, et al. (1977) Development of improved cholera vaccine based on subunit toxoid. Nature 269: 602-604.
32. Pierce NF, Cray WC Jr, Sacci JB Jr, (1982) Oral immunization of dogs with purified cholera toxin, crude cholera toxin, or B subunit: evidence for synergistic protection by antitoxic and antibacterial mechanisms. Infect Immun 37: 687-694.
33. Srivastava R, Sinha VB, Srivastava BS, (1979) Re-evaluation of antibacterial and antitoxin immunities in experimental cholera. Indian J Med Res 70: 369-373.
34. Price GA, Holmes RK, (2012) Evaluation of TcpF-A2-CTB chimera and evidence of additive protective efficacy of immunizing with TcpF and CTB in the suckling mouse model of cholera. PLoS One 7: e42434.
35. Ujiiye A, Nakatomi M, Utsunomiya A, Mitsui K, Sogame S, et al. (1968) Experimental Cholera in Mice I. First Report on the Oral Infection. Tropical Medicine 10: 65-71.
36. Appleby P, Catty D, (1983) Transmission of immunoglobulin to foetal and neonatal mice. J Reprod Immunol 5: 203-213.
37. Schild S, Nelson EJ, Bishop AL, Camilli A, (2009) Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera. Infect Immun 77: 472-484.
38. Ujiye A, Kobari K (1970) Protective effect on infections with Vibrio cholerae in suckling mice caused by the passive immunization with milk of immune mothers. J Infect Dis 121: Suppl 121: 150+.
39. Aldinger KA, Sokoloff G, Rosenberg DM, Palmer AA, Millen KJ, (2009) Genetic variation and population substructure in outbred CD-1 mice: implications for genome-wide association studies. PLoS One 4: e4729.
40. Glass RI, Holmgren J, Haley CE, Khan MR, Svennerholm AM, et al. (1985) Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. Am J Epidemiol 121: 791-796.
41. Larocque RC, Sabeti P, Duggal P, Chowdhury F, Khan AI, et al. (2009) A variant in long palate, lung and nasal epithelium clone 1 is associated with cholera in a Bangladeshi population. Genes Immun 10: 267-272.
42. Nelson EJ, Harris JB, Morris JG Jr, Calderwood SB, Camilli A, (2009) Cholera transmission: the host, pathogen and bacteriophage dynamic. Nat Rev Microbiol 7: 693-702.
43. Bishop AL, Camilli A, (2011) Vibrio cholerae: lessons for mucosal vaccine design. Expert Rev Vaccines 10: 79-94.
44. Waldman RH, Bencic Z, Sakazaki R, Sinha R, Ganguly R, et al. (1971) Cholera immunology. I. Immunoglobulin levels in serum, fluid from the small intestine, and feces from patients with cholera and noncholeraic diarrhea during illness and convalescence. J Infect Dis 123: 579-586.
45. Waldman RH, Bencic Z, Sinha R, Deb BC, Sakazaki R, et al. (1972) Cholera immunology. II. Serum and intestinal secretion antibody response after naturally occurring cholera. J Infect Dis 126: 401-407.
46. Uddin T, Harris JB, Bhuiyan TR, Shirin T, Uddin MI, et al. (2011) Mucosal immunologic responses in cholera patients in Bangladesh. Clin Vaccine Immunol 18: 506-512.
47. Harris AM, Bhuiyan MS, Chowdhury F, Khan AI, Hossain A, et al. (2009) Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect Immun 77: 3850-3856.
48. Patel SM, Rahman MA, Mohasin M, Riyadh MA, Leung DT, et al. (2012) Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh. Clin Vaccine Immunol 19: 842-848.
49. Alam MM, Riyadh MA, Fatema K, Rahman MA, Akhtar N, et al. (2011) Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera. Clin Vaccine Immunol 18: 844-850.
50. Jayasekera CR, Harris JB, Bhuiyan S, Chowdhury F, Khan AI, et al. (2008) Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1. J Infect Dis 198: 1055-1061.
51. Schild S, Nelson EJ, Camilli A, (2008) Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice. Infect Immun 76: 4554-4563.
52. Majumdar AS, Ghose AC, (1981) Evaluation of the biological properties of different classes of human antibodies in relation to cholera. Infect Immun 32: 9-14.
53. Price GA, Russell MW, Cornelissen CN, (2005) Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice. Infect Immun 73: 3945-3953.
54. Reed LJ, Muench H, (1938) A simple method of estimating fifty percent endpoints. The American Journal of Hygiene 27: 493-497.